Skip to main content
Clinical Trials/NCT01536158
NCT01536158CompletedPhase 4

Oral Paracetamol Versus Oral Ibuprofen Treatment

Zekai Tahir Burak Women's Health Research and Education Hospital1 site in 1 country80 target enrollmentStarted: February 2012Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
Efficacy and Safety of Oral Paracetamol Versus Oral Ibuprofen

Study Overview

Brief Summary

The purpose of this study is to determine whether oral paracetamol or ibuprofen has a better or same efficacy and tolerance in closure of patent ductus arteriosus in preterm infants.

Detailed Description

To determine whether oral paracetamol or ibuprofen has a better or same efficacy and tolerance in closure of patent ductus arteriosus in preterm infants.

Eighty preterm infants with patent ductus arteriosus will be enrolled in this prospective-randomized study. Patients will receive oral ibuprofen at an initial dose of 10 mg/kg, followed by 5 mg/kg at 24 and 48 h or oral paracetamol 15 mg/kg per dose every 6 hours.

One of the following echocardiographic criteria of a duct size >1.5 mm, a left atrium-to-aorta ratio >1.5, left-to-right shunting of blood, end diastolic reversal of blood flow in the aorta, or poor cardiac function in addition signs of patent ductus arteriosis determined the need of treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
2 Days to 10 Days (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Birth weight below 1250 gram
  • Diagnosed patent ductus arteriosus by Echocardiographic examination

Exclusion Criteria

  • Accompanied other congenital cardiac anomalies
  • Urine output of less than 1 ml/kg/h during the preceding 8 h,
  • Serum creatinine level >1.6 mg/dl,
  • Platelet count <60,000/mm3,
  • Liver failure,
  • Hyperbilirubinemia requiring exchange transfusion
  • Severe intracranial bleeding (Grade III - IV)
  • Intestinal abnormality and necrotising enterocolitis

Arms & Interventions

Oral paracetamol

Active Comparator

Patients will receive oral paracetamol 15 mg/kg per dose every 6 hours.

Intervention: Oral paracetamol (Drug)

Oral ibuprofen

Active Comparator

Patients will receive oral ibuprofen at an initial dose of 10 mg/kg, followed by 5 mg/kg at 24 and 48 h.

Intervention: Oral ibuprofen (Drug)

Outcomes

Primary Outcomes

Efficacy and Safety of Oral Paracetamol Versus Oral Ibuprofen

Time Frame: Until discharge

To compare the closure rate of patent ductus arteriosus after oral paracetamol or oral ibuprofen treatment

Secondary Outcomes

  • Long term effects of oral paracetamol versus oral ibuprofen treatment in preterm infants(corrected 36 weeks or until discharge)

Investigators

Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mehmet Yekta

Zekai Tahir Burak Maternity and Teaching Hospital

Zekai Tahir Burak Women's Health Research and Education Hospital

Study Sites (1)

Loading locations...

Similar Trials

Oral Paracetamol Versus Oral Ibuprofen in... | Clinical Trial